Links between human LINE-1 retrotransposons and hepatitis virus-related hepatocellular carcinoma

Research output: Contribution to journalShort surveypeer-review

13 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) accounts for approximately 80% of liver cancers, the third most frequent cause of cancer mortality. The most prevalent risk factors for HCC are infections by hepatitis B or hepatitis C virus. Findings suggest that hepatitis virus-related HCC might be a cancer in which LINE-1 retrotransposon, often termed L1, activity plays a potential role. Firstly, hepatitis viruses can suppress host defense factors that also control L1 mobilization. Secondly, many recent studies also have indicated that hypomethylation of L1 affects the prognosis of HCC patients. Thirdly, endogenous L1 retrotransposition was demonstrated to activate oncogenic pathways in HCC. Fourthly, several L1 chimeric transcripts with host or viral genes are found in hepatitis virus-related HCC. Such lines of evidence suggest a linkage between L1 retrotransposons and hepatitis virus-related HCC. Here, I briefly summarize current understandings of the association between hepatitis virus-related HCC and L1. Then, I discuss potential mechanisms of how hepatitis viruses drive the development of HCC via L1 retrotransposons. An increased understanding of the contribution of L1 to hepatitis virus-related HCC may provide unique insights related to the development of novel therapeutics for this disease.

Original languageEnglish
Article number21
JournalFrontiers in Chemistry
Volume4
Issue numberMAY
DOIs
Publication statusPublished - 2016
Externally publishedYes

Keywords

  • Hepatitis B virus (HBV)
  • Hepatitis C virus (HCV)
  • Hepatocellular carcinoma
  • L1
  • Retrotransposon

ASJC Scopus subject areas

  • Chemistry(all)

Fingerprint

Dive into the research topics of 'Links between human LINE-1 retrotransposons and hepatitis virus-related hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this